Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.
2.

Development of purine-scaffold small molecule inhibitors of Hsp90.

Chiosis G, Lucas B, Huezo H, Solit D, Basso A, Rosen N.

Curr Cancer Drug Targets. 2003 Oct;3(5):371-6. Review.

PMID:
14529388
3.

Discovery and development of purine-scaffold Hsp90 inhibitors.

Chiosis G.

Curr Top Med Chem. 2006;6(11):1183-91. Review.

PMID:
16842155
4.

Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis.

Tsutsumi S, Neckers L.

Cancer Sci. 2007 Oct;98(10):1536-9. Epub 2007 Jul 23. Review.

5.
6.

Recent advances in Hsp90 inhibitors as antitumor agents.

Messaoudi S, Peyrat JF, Brion JD, Alami M.

Anticancer Agents Med Chem. 2008 Oct;8(7):761-82. Review.

PMID:
18855578
7.

STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer.

Wang Y, Trepel JB, Neckers LM, Giaccone G.

Curr Opin Investig Drugs. 2010 Dec;11(12):1466-76. Review.

PMID:
21154128
9.

Purine-scaffold Hsp90 inhibitors.

Taldone T, Chiosis G.

Curr Top Med Chem. 2009;9(15):1436-46. Review.

10.

Structure-based and in silico design of Hsp90 inhibitors.

Sgobba M, Rastelli G.

ChemMedChem. 2009 Sep;4(9):1399-409. doi: 10.1002/cmdc.200900256. Review.

PMID:
19685544
11.
12.

Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.

Stravopodis DJ, Margaritis LH, Voutsinas GE.

Curr Med Chem. 2007;14(29):3122-38. Review.

PMID:
18220746
13.

Hsp90: a novel target for cancer therapy.

Solit DB, Rosen N.

Curr Top Med Chem. 2006;6(11):1205-14. Review.

PMID:
16842157
14.

Hsp90: an emerging target for breast cancer therapy.

Beliakoff J, Whitesell L.

Anticancer Drugs. 2004 Aug;15(7):651-62. Review.

PMID:
15269596
Items per page

Supplemental Content

Write to the Help Desk